Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses ms drug for approval FiercePharma 3d Pharma
Dupi whoopie: Sanofi/Regeneron cheered for sales, new approval BioWorld 4d Regeneron Pharma Biotech Article paywall
Sanofi welcomes incoming CEO with sales lift pharmaphorum 4d Mergers and Acquisitions Hepatitis Pharma
With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity FiercePharma 4d Pharma
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses Sanofi (Press Release) 3d
Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval FiercePharma 3d
Regulatory round-up: Novartis, Sanofi and Arrowhead secure CHMP blessings Pharmaceutical Technology 3d
